339 related articles for article (PubMed ID: 36719370)
1. Unlocking life-threatening COVID-19 through two types of inborn errors of type I IFNs.
Casanova JL; Anderson MS
J Clin Invest; 2023 Feb; 133(3):. PubMed ID: 36719370
[TBL] [Abstract][Full Text] [Related]
2. Insufficient type I IFN immunity underlies life-threatening COVID-19 pneumonia.
Bastard P; Zhang Q; Cobat A; Jouanguy E; Zhang SY; Abel L; Casanova JL
C R Biol; 2021 Jun; 344(1):19-25. PubMed ID: 34213846
[TBL] [Abstract][Full Text] [Related]
3. Infection-induced inflammation from specific inborn errors of immunity to COVID-19.
Ku CL; Chen IT; Lai MZ
FEBS J; 2021 Sep; 288(17):5021-5041. PubMed ID: 33971084
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies against type I IFNs in patients with life-threatening COVID-19.
Bastard P; Rosen LB; Zhang Q; Michailidis E; Hoffmann HH; Zhang Y; Dorgham K; Philippot Q; Rosain J; Béziat V; Manry J; Shaw E; Haljasmägi L; Peterson P; Lorenzo L; Bizien L; Trouillet-Assant S; Dobbs K; de Jesus AA; Belot A; Kallaste A; Catherinot E; Tandjaoui-Lambiotte Y; Le Pen J; Kerner G; Bigio B; Seeleuthner Y; Yang R; Bolze A; Spaan AN; Delmonte OM; Abers MS; Aiuti A; Casari G; Lampasona V; Piemonti L; Ciceri F; Bilguvar K; Lifton RP; Vasse M; Smadja DM; Migaud M; Hadjadj J; Terrier B; Duffy D; Quintana-Murci L; van de Beek D; Roussel L; Vinh DC; Tangye SG; Haerynck F; Dalmau D; Martinez-Picado J; Brodin P; Nussenzweig MC; Boisson-Dupuis S; Rodríguez-Gallego C; Vogt G; Mogensen TH; Oler AJ; Gu J; Burbelo PD; Cohen JI; Biondi A; Bettini LR; D'Angio M; Bonfanti P; Rossignol P; Mayaux J; Rieux-Laucat F; Husebye ES; Fusco F; Ursini MV; Imberti L; Sottini A; Paghera S; Quiros-Roldan E; Rossi C; Castagnoli R; Montagna D; Licari A; Marseglia GL; Duval X; Ghosn J; ; ; ; ; ; ; ; ; ; ; Tsang JS; Goldbach-Mansky R; Kisand K; Lionakis MS; Puel A; Zhang SY; Holland SM; Gorochov G; Jouanguy E; Rice CM; Cobat A; Notarangelo LD; Abel L; Su HC; Casanova JL
Science; 2020 Oct; 370(6515):. PubMed ID: 32972996
[TBL] [Abstract][Full Text] [Related]
5. Human Genomics of COVID-19 Pneumonia: Contributions of Rare and Common Variants.
Cobat A; Zhang Q; ; Abel L; Casanova JL; Fellay J
Annu Rev Biomed Data Sci; 2023 Aug; 6():465-486. PubMed ID: 37196358
[TBL] [Abstract][Full Text] [Related]
6. Life-Threatening COVID-19: Defective Interferons Unleash Excessive Inflammation.
Zhang Q; Bastard P; Bolze A; Jouanguy E; Zhang SY; ; Cobat A; Notarangelo LD; Su HC; Abel L; Casanova JL
Med; 2020 Dec; 1(1):14-20. PubMed ID: 33363283
[TBL] [Abstract][Full Text] [Related]
7. NFKB2 haploinsufficiency identified via screening for IFN-α2 autoantibodies in children and adolescents hospitalized with SARS-CoV-2-related complications.
Bodansky A; Vazquez SE; Chou J; Novak T; Al-Musa A; Young C; Newhams M; Kucukak S; Zambrano LD; Mitchell A; Wang CY; Moffitt K; Halasa NB; Loftis LL; Schwartz SP; Walker TC; Mack EH; Fitzgerald JC; Gertz SJ; Rowan CM; Irby K; Sanders RC; Kong M; Schuster JE; Staat MA; Zinter MS; Cvijanovich NZ; Tarquinio KM; Coates BM; Flori HR; Dahmer MK; Crandall H; Cullimore ML; Levy ER; Chatani B; Nofziger R; ; Geha RS; DeRisi J; Campbell AP; Anderson M; Randolph AG
J Allergy Clin Immunol; 2023 Apr; 151(4):926-930.e2. PubMed ID: 36509151
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies Neutralizing Type I IFNs in the Bronchoalveolar Lavage of at Least 10% of Patients During Life-Threatening COVID-19 Pneumonia.
Philippot Q; Fekkar A; Gervais A; Le Voyer T; Boers LS; Conil C; Bizien L; de Brabander J; Duitman JW; Romano A; Rosain J; Blaize M; Migaud M; Jeljeli M; Hammadi B; Desmons A; Marchal A; ; ; Mayaux J; Zhang Q; Jouanguy E; Borie R; Crestani B; Luyt CE; Adle-Biassette H; Sene D; Megarbane B; Cobat A; Bastard P; Bos LDJ; Casanova JL; Puel A
J Clin Immunol; 2023 Aug; 43(6):1093-1103. PubMed ID: 37209324
[TBL] [Abstract][Full Text] [Related]
9. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19.
Matuozzo D; Talouarn E; Marchal A; Zhang P; Manry J; Seeleuthner Y; Zhang Y; Bolze A; Chaldebas M; Milisavljevic B; Gervais A; Bastard P; Asano T; Bizien L; Barzaghi F; Abolhassani H; Abou Tayoun A; Aiuti A; Alavi Darazam I; Allende LM; Alonso-Arias R; Arias AA; Aytekin G; Bergman P; Bondesan S; Bryceson YT; Bustos IG; Cabrera-Marante O; Carcel S; Carrera P; Casari G; Chaïbi K; Colobran R; Condino-Neto A; Covill LE; Delmonte OM; El Zein L; Flores C; Gregersen PK; Gut M; Haerynck F; Halwani R; Hancerli S; Hammarström L; Hatipoğlu N; Karbuz A; Keles S; Kyheng C; Leon-Lopez R; Franco JL; Mansouri D; Martinez-Picado J; Metin Akcan O; Migeotte I; Morange PE; Morelle G; Martin-Nalda A; Novelli G; Novelli A; Ozcelik T; Palabiyik F; Pan-Hammarström Q; de Diego RP; Planas-Serra L; Pleguezuelo DE; Prando C; Pujol A; Reyes LF; Rivière JG; Rodriguez-Gallego C; Rojas J; Rovere-Querini P; Schlüter A; Shahrooei M; Sobh A; Soler-Palacin P; Tandjaoui-Lambiotte Y; Tipu I; Tresoldi C; Troya J; van de Beek D; Zatz M; Zawadzki P; Al-Muhsen SZ; Alosaimi MF; Alsohime FM; Baris-Feldman H; Butte MJ; Constantinescu SN; Cooper MA; Dalgard CL; Fellay J; Heath JR; Lau YL; Lifton RP; Maniatis T; Mogensen TH; von Bernuth H; Lermine A; Vidaud M; Boland A; Deleuze JF; Nussbaum R; Kahn-Kirby A; Mentre F; Tubiana S; Gorochov G; Tubach F; Hausfater P; ; ; ; ; ; ; ; ; ; Meyts I; Zhang SY; Puel A; Notarangelo LD; Boisson-Dupuis S; Su HC; Boisson B; Jouanguy E; Casanova JL; Zhang Q; Abel L; Cobat A
Genome Med; 2023 Apr; 15(1):22. PubMed ID: 37020259
[TBL] [Abstract][Full Text] [Related]
10. Plasma Exchange to Rescue Patients with Autoantibodies Against Type I Interferons and Life-Threatening COVID-19 Pneumonia.
de Prost N; Bastard P; Arrestier R; Fourati S; Mahévas M; Burrel S; Dorgham K; Gorochov G; Tandjaoui-Lambiotte Y; Azzaoui I; Fernandes I; Combes A; Casanova JL; Mekontso-Dessap A; Luyt CE
J Clin Immunol; 2021 Apr; 41(3):536-544. PubMed ID: 33616813
[TBL] [Abstract][Full Text] [Related]
11. Recessive inborn errors of type I IFN immunity in children with COVID-19 pneumonia.
Zhang Q; Matuozzo D; Le Pen J; Lee D; Moens L; Asano T; Bohlen J; Liu Z; Moncada-Velez M; Kendir-Demirkol Y; Jing H; Bizien L; Marchal A; Abolhassani H; Delafontaine S; Bucciol G; ; Bayhan GI; Keles S; Kiykim A; Hancerli S; Haerynck F; Florkin B; Hatipoglu N; Ozcelik T; Morelle G; Zatz M; Ng LFP; Lye DC; Young BE; Leo YS; Dalgard CL; Lifton RP; Renia L; Meyts I; Jouanguy E; Hammarström L; Pan-Hammarström Q; Boisson B; Bastard P; Su HC; Boisson-Dupuis S; Abel L; Rice CM; Zhang SY; Cobat A; Casanova JL
J Exp Med; 2022 Aug; 219(8):. PubMed ID: 35708626
[TBL] [Abstract][Full Text] [Related]
12. Human genetics of SARS-CoV-2 infection and critical COVID-19.
Mogensen TH
Clin Microbiol Infect; 2022 Nov; 28(11):1417-1421. PubMed ID: 35218979
[TBL] [Abstract][Full Text] [Related]
13. Interfering with Interferons: A Critical Mechanism for Critical COVID-19 Pneumonia.
Su HC; Jing H; Zhang Y; Casanova JL
Annu Rev Immunol; 2023 Apr; 41():561-585. PubMed ID: 37126418
[TBL] [Abstract][Full Text] [Related]
14. Mild COVID-19 despite autoantibodies against type I IFNs in autoimmune polyendocrine syndrome type 1.
Meisel C; Akbil B; Meyer T; Lankes E; Corman VM; Staudacher O; Unterwalder N; Kölsch U; Drosten C; Mall MA; Kallinich T; Schnabel D; Goffinet C; von Bernuth H
J Clin Invest; 2021 Jul; 131(14):. PubMed ID: 34061776
[TBL] [Abstract][Full Text] [Related]
15. Type I interferons and SARS-CoV-2: from cells to organisms.
Bastard P; Zhang Q; Zhang SY; Jouanguy E; Casanova JL
Curr Opin Immunol; 2022 Feb; 74():172-182. PubMed ID: 35149239
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 mRNA vaccine, but not a viral vector-based vaccine, promotes neutralizing anti-type I interferon autoantibody production in a small group of healthy individuals.
Xu W; Wen X; Cong X; Jiang W
J Med Virol; 2023 Oct; 95(10):e29137. PubMed ID: 37792386
[TBL] [Abstract][Full Text] [Related]
17. Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1.
Bastard P; Orlova E; Sozaeva L; Lévy R; James A; Schmitt MM; Ochoa S; Kareva M; Rodina Y; Gervais A; Le Voyer T; Rosain J; Philippot Q; Neehus AL; Shaw E; Migaud M; Bizien L; Ekwall O; Berg S; Beccuti G; Ghizzoni L; Thiriez G; Pavot A; Goujard C; Frémond ML; Carter E; Rothenbuhler A; Linglart A; Mignot B; Comte A; Cheikh N; Hermine O; Breivik L; Husebye ES; Humbert S; Rohrlich P; Coaquette A; Vuoto F; Faure K; Mahlaoui N; Kotnik P; Battelino T; Trebušak Podkrajšek K; Kisand K; Ferré EMN; DiMaggio T; Rosen LB; Burbelo PD; McIntyre M; Kann NY; Shcherbina A; Pavlova M; Kolodkina A; Holland SM; Zhang SY; Crow YJ; Notarangelo LD; Su HC; Abel L; Anderson MS; Jouanguy E; Neven B; Puel A; Casanova JL; Lionakis MS
J Exp Med; 2021 Jul; 218(7):. PubMed ID: 33890986
[TBL] [Abstract][Full Text] [Related]
18. Inherited IFNAR1 Deficiency in a Child with Both Critical COVID-19 Pneumonia and Multisystem Inflammatory Syndrome.
Abolhassani H; Landegren N; Bastard P; Materna M; Modaresi M; Du L; Aranda-Guillén M; Sardh F; Zuo F; Zhang P; Marcotte H; Marr N; Khan T; Ata M; Al-Ali F; Pescarmona R; Belot A; Béziat V; Zhang Q; Casanova JL; Kämpe O; Zhang SY; Hammarström L; Pan-Hammarström Q
J Clin Immunol; 2022 Apr; 42(3):471-483. PubMed ID: 35091979
[TBL] [Abstract][Full Text] [Related]
19. Human type I IFN deficiency does not impair B cell response to SARS-CoV-2 mRNA vaccination.
Sokal A; Bastard P; Chappert P; Barba-Spaeth G; Fourati S; Vanderberghe A; Lagouge-Roussey P; Meyts I; Gervais A; Bouvier-Alias M; Azzaoui I; Fernández I; de la Selle A; Zhang Q; Bizien L; Pellier I; Linglart A; Rothenbuhler A; Marcoux E; Anxionnat R; Cheikh N; Léger J; Amador-Borrero B; Fouyssac F; Menut V; Goffard JC; Storey C; Demily C; Mallebranche C; Troya J; Pujol A; Zins M; Tiberghien P; Gray PE; McNaughton P; Sullivan A; Peake J; Levy R; Languille L; Rodiguez-Gallego C; Boisson B; Gallien S; Neven B; Michel M; Godeau B; Abel L; Rey FA; Weill JC; Reynaud CA; Tangye SG; Casanova JL; Mahévas M
J Exp Med; 2023 Jan; 220(1):. PubMed ID: 36342455
[TBL] [Abstract][Full Text] [Related]
20. Neutralizing Autoantibodies to Type I IFNs in >10% of Patients with Severe COVID-19 Pneumonia Hospitalized in Madrid, Spain.
Troya J; Bastard P; Planas-Serra L; Ryan P; Ruiz M; de Carranza M; Torres J; Martínez A; Abel L; Casanova JL; Pujol A
J Clin Immunol; 2021 Jul; 41(5):914-922. PubMed ID: 33851338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
